Wade Wirta and Steven Schwager sit down to discuss the strengths and weaknesses of adaptive design as well as the logistical considerations to manage these complex trials.
Catch up on last week's news highlights from our social media channels below.
Happy holidays from Geeks Talk Clinical!
The adoption rate of adaptive clinical trial designs will increase dramatically in the coming years.
We sat down with Steve Smith, our chief patient advocate, to chat about last month’s FDA guidance issued on rare disease drug development.